← Back to Search

Other

Parenting Intervention for Postpartum Depression (MInD Trial)

Phase 2

Recruiting

Led By Amritha S Bhat, MD, MPH

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥ 18 years

English speaking pregnant women between gestational age (GA) 13 - 24 weeks

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30-34 weeks gestational age, 6 weeks postpartum, 3 months postpartum, 6 months postpartum

Awards & highlights

MInD Trial Summary

This trial tests if a parenting intervention can help reduce postpartum depression and improve mental health and parenting outcomes.

Who is the study for?

This trial is for English-speaking pregnant women aged 18 or older, who are between 13-24 weeks into their pregnancy and have a depression score (EPDS) of 10 or higher. They must be able to send and receive text messages.Check my eligibility

What is being tested?

The study is testing if adding a parenting program called 'Promoting First Relationships-Brief' to the usual care helps improve mental health and parenting outcomes in women with postpartum depression compared to just the usual care.See study design

What are the potential side effects?

Since this trial involves counseling and educational interventions rather than medications, side effects may include emotional discomfort during discussions but are generally considered low-risk.

MInD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am pregnant, speak English, and am between 13-24 weeks along.

MInD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30-34 weeks gestational age, 6 weeks postpartum, 3 months postpartum, 6 months postpartum

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30-34 weeks gestational age, 6 weeks postpartum, 3 months postpartum, 6 months postpartum

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30-34 weeks gestational age, 6 weeks postpartum, 3 months postpartum, 6 months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from Baseline in Perinatal Depression Symptomology on the Edinburgh Postnatal Depression Scale (EPDS)

Secondary outcome measures

Change from Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)

Change from Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)

Change from Postpartum Baseline in Dyadic Interaction

+3 more

MInD Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Maternal Infant Dyadic CareExperimental Treatment2 Interventions

Perinatal collaborative care and Promoting First Relationships-Brief

Group II: ControlActive Control1 Intervention

Perinatal collaborative care only

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor

1,741 Previous Clinical Trials

1,847,706 Total Patients Enrolled

1 Trials studying Postpartum Depression

40 Patients Enrolled for Postpartum Depression

National Institute of Mental Health (NIMH)NIH

2,786 Previous Clinical Trials

2,689,649 Total Patients Enrolled

25 Trials studying Postpartum Depression

8,143 Patients Enrolled for Postpartum Depression

Amritha S Bhat, MD, MPHPrincipal InvestigatorUniversity of Washington

1 Previous Clinical Trials

60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any slots left to join this clinical research study?

"This clinical trial, which was first made available on November 1st 2022 is in the process of recruiting patients. The study details were last updated on November 20th 2023 according to clinicaltrials.gov."

Answered by AI

What is the aggregate number of participants engaged in this experiment?

"Affirmative. The information on clinicaltrials.gov reveals that this experiment has been actively recruiting patients since November 1st 2022, and the most recent amendments were made on November 20th 2023. This trial hopes to recruit 60 subjects from a single medical centre."

Answered by AI

Has the FDA authorized Maternal Infant Dyadic Care for widespread use?

"Our team at Power decided to rate the safety of Maternal Infant Dyadic Care a 1, as clinical evidence for this intervention is limited and mainly in its early stages."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care

Amritha Subray Bhat 2022. "A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04998721.